A Polypill for Secondary Prevention of Ischemic Heart Disease
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 1200 participants.
Also called NCT03541109
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 1,200 participants
- Registry
-
NCT03541109
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Iran
- Registry status
- Unknown status
Technical summary
Registry record NCT03541109. Randomized; no masking; primary purpose treatment. Start 2019-05-20 (actual); primary completion 2023-08 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Polypill for Secondary Prevention of Ischemic Heart Disease
- Condition
- Acute Myocardial Infarction
- Condition
- ST Elevation Myocardial Infarction
- Condition
- Non-ST Elevation Myocardial Infarction
- Intervention (Drug)
- Polypill
- Lead sponsor
- Isfahan University of Medical Sciences
- Collaborator
- Tehran University of Medical Sciences
Record details
- Record id
cardio:ct-nct03541109- Content hash
b947f02b4b0d8bd5e5231eeae5867b756e66b8387ebb63c42856f893adddfc78